Posted by Michael Wonder on 13 Sep 2018
Limiting state flexibility in drug pricing
13 September 2018 - To reduce the burden of high-cost, low-value drugs, Massachusetts has proposed establishing a closed formulary, in which certain drugs can be excluded from coverage, for its Medicaid program.
In late June, however, CMS denied the state’s request without explanation.
